# A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer

> **NCT04337099** · — · AVAILABLE · sponsor: **Matrix Biomed, Inc.**

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** MBM-02 (Tempol)

## Key facts

- **NCT ID:** NCT04337099
- **Lead sponsor:** Matrix Biomed, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2021-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04337099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04337099, "A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04337099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*